ADPT
Price
$10.42
Change
-$0.08 (-0.76%)
Updated
Jul 18, 04:21 PM (EDT)
Capitalization
1.6B
18 days until earnings call
DNA
Price
$10.13
Change
+$0.53 (+5.52%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
571.27M
Interact to see
Advertisement

ADPT vs DNA

Header iconADPT vs DNA Comparison
Open Charts ADPT vs DNABanner chart's image
Adaptive Biotechnologies
Price$10.42
Change-$0.08 (-0.76%)
Volume$1.81K
Capitalization1.6B
Ginkgo Bioworks Holdings
Price$10.13
Change+$0.53 (+5.52%)
Volume$7.86K
Capitalization571.27M
ADPT vs DNA Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. DNA commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and DNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (ADPT: $10.50 vs. DNA: $9.76)
Brand notoriety: ADPT: Notable vs. DNA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 90% vs. DNA: 97%
Market capitalization -- ADPT: $1.6B vs. DNA: $571.27M
ADPT [@Biotechnology] is valued at $1.6B. DNA’s [@Biotechnology] market capitalization is $571.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileDNA’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • DNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADPT and DNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while DNA’s TA Score has 3 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 4 bearish.
  • DNA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ADPT is a better buy in the short-term than DNA.

Price Growth

ADPT (@Biotechnology) experienced а -13.08% price change this week, while DNA (@Biotechnology) price change was -9.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.22%, and the average quarterly price growth was +35.00%.

Reported Earning Dates

ADPT is expected to report earnings on Oct 30, 2025.

DNA is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($1.6B) has a higher market cap than DNA($571M). ADPT YTD gains are higher at: 75.146 vs. DNA (-0.611). ADPT has higher annual earnings (EBITDA): -111.63M vs. DNA (-387.59M). DNA has more cash in the bank: 517M vs. ADPT (193M). ADPT has less debt than DNA: ADPT (86.9M) vs DNA (435M). DNA has higher revenues than ADPT: DNA (237M) vs ADPT (190M).
ADPTDNAADPT / DNA
Capitalization1.6B571M279%
EBITDA-111.63M-387.59M29%
Gain YTD75.146-0.611-12,299%
P/E RatioN/AN/A-
Revenue190M237M80%
Total Cash193M517M37%
Total Debt86.9M435M20%
FUNDAMENTALS RATINGS
ADPT: Fundamental Ratings
ADPT
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADPTDNA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTCAX19.48N/A
N/A
BNY Mellon Sust US Equity A
TEOIX9.63N/A
N/A
Transamerica Emerging Markets Eq I
FHUMX15.16N/A
N/A
Federated Hermes US SMID Institutional
JHDAX18.96N/A
N/A
JPMorgan Hedged Equity 2 A
VLNPX41.45N/A
N/A
Voya Small Cap Growth R6